Kodiak Sciences Inc. (KOD)
NASDAQ: KOD · Real-Time Price · USD
41.41
+0.39 (0.95%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Kodiak Sciences Market Cap
Kodiak Sciences has a market cap or net worth of $2.59 billion as of July 24, 2026. Its market cap has increased by 612.01% in one year.
Market Cap
2.59B
Enterprise Value
2.47B
1-Year Change
612.01%
Ranking
Category
Stock Price
$41.41
ChartMarket Cap Chart
Since October 4, 2018, Kodiak Sciences's market cap has increased from $357.63M to $2.59B, an increase of 622.99%. That is a compound annual growth rate of 28.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 2.59B | 49.22% |
| Dec 31, 2025 | 1.73B | 231.69% |
| Dec 31, 2024 | 522.39M | 228.65% |
| Dec 29, 2023 | 158.95M | -57.33% |
| Dec 30, 2022 | 372.50M | -91.44% |
| Dec 31, 2021 | 4.35B | -41.22% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Oct 4, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 2.77B |
| uniQure | 2.72B |
| Ultragenyx Pharmaceutical | 2.71B |
| AtaiBeckley | 2.65B |
| Vera Therapeutics | 2.57B |
| Beam Therapeutics | 2.57B |
| Immunome | 2.53B |
| Tarsus Pharmaceuticals | 2.47B |